Phase
Condition
N/ATreatment
0.9% Sodium Chloride
CBL-514 Injection
Clinical Study ID
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female, aged ≥ 18 years old.
Body mass index (BMI) > 18.5 and < 30 kg/m2 and body weight ≥ 50 kg.
Participant has moderate or severe abdominal fat as assessed by the Investigator on the CR-AFRS and by the participant on the PR-AFRS.
Dissatisfaction with the abdominal fat reported by participant as 'Extremely Dissatisfied', 'Dissatisfied', or 'Slightly dissatisfied'.
Participant maintained a stable lifestyle.
Voluntarily signs the Informed Consent Form and is physically and mentally capable of participating in the study, and willing to adhere to study procedures.
Exclusion Criteria
Female participant of childbearing potential who is not willing to commit to an acceptable contraceptive method, or who is currently pregnant or lactating. Male participant who is not willing to commit to using condom consistently and refraining from sperm donation.
Participant who has coagulation disorders.
Participant has delayed wound healing or poorly controlled diabetes.
Participant has active malignancies or is currently being evaluated for a possible malignancy.
Participant has a history of risk factors for torsade de pointes, currently has any uncontrolled cardiovascular disease, or any clinically significant finding on baseline ECG.
Participant has a history of peripheral arterial disease or clinically significant venous disease involving the lower extremities.
Participant has a history of trypanophobia, the extreme fear of medical procedures involving injections or needles, or who experiences vasovagal syncope and faints at the sight of blood or a needle.
Participant has a visible Panniculus on the abdomen in standing position.
Participant has severe abdominal visceral fat.
Participant has skin conditions, which would pose risk to the participant if receiving the IP or interfere with the safety or efficacy evaluation.
Participant has undergone the procedures at the treatment area that may affect IP administration.
Participant with contraindications to MRI imaging.
Participant is on prescription or over-the-counter weight reduction medication, weight reduction programs, or taking oral or injectable GLP-1 agonists.
Participant is undergoing long-term systemic steroid or immunosuppressive therapy.
Participant is taking or will take any medication that is known strong inhibitor, inducer or is a sensitative substrate for CYP enzymes, or medication with narrow therapeutic index.
Participant with a history of hypersensitivity to local anesthesia.
Participant with known allergies or significant adverse reaction to the IP.
Participant with liver cirrhosis or abnormal liver function, or with any hepatic condition that interferes with the safety or efficacy assessments.
Participant with any renal impairment.
Participant has received any investigational product within 3 months.
Participant considered to be unreliable or incapable of complying with the requirements of the protocol.
Study Design
Study Description
Connect with a study center
Investigational site 12
Vancouver, British Columbia V5Z1H4
CanadaSite Not Available
Investigational site 13
Toronto, Ontario M4W2N4
CanadaSite Not Available
Investigational site 1
Encinitas, California 92024
United StatesActive - Recruiting
Investigational site 2
West Palm Beach, Florida 33401
United StatesSite Not Available
Investigational site 3
Chicago, Illinois 60610
United StatesSite Not Available
Investigational site 4
Baton Rouge, Louisiana 70809
United StatesActive - Recruiting
Investigational site 5
Hunt Valley, Maryland 21030
United StatesActive - Recruiting
Investigational site 6
Omaha, Nebraska 68144
United StatesActive - Recruiting
Investigational site 7
Hackensack, New Jersey 07601
United StatesSite Not Available
Investigational site 8
New York, New York 10028
United StatesActive - Recruiting
Investigational site 9
Charlotte, North Carolina 28207
United StatesSite Not Available
Investigational site 10
Nashville, Tennessee 37215
United StatesSite Not Available
Investigational site 11
Pflugerville, Texas 78660
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.